Related Experiment Video
Updated: Mar 7, 2026
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.2K
Fine-tuning the CAR spacer improves T-cell potency
Norihiro Watanabe1, Pradip Bajgain1, Sujita Sukumaran1
1Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, and Houston Methodist Hospital , Houston, Texas, USA.
Oncoimmunology
|February 10, 2017
Summary
Modifying the spacer component of chimeric antigen receptor (CAR) T-cells can significantly enhance their ability to target tumors. These molecular refinements improve CAR T-cell potency and antitumor activity.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Chimeric antigen receptor (CAR) T-cell therapy is a promising cancer treatment.
- Current strategies focus on adding genes to enhance CAR T-cell function.
- The impact of modifying existing CAR components is less explored.
Purpose of the Study:
- To investigate if molecular refinements to the CAR spacer can enhance CAR T-cell potency.
- To understand how CAR spacer modifications affect biological processes relevant to cancer therapy.
Main Methods:
- Engineered T-cells with modified CAR spacers were developed.
- Biological processes such as tonic signaling, cell aging, tumor localization, and antigen recognition were analyzed.
- In vivo antitumor activity was assessed.
Main Results:
- Molecular refinements to the CAR spacer significantly impacted tonic signaling and cell aging.
- Modified CAR spacers improved tumor localization and antigen recognition.
- Enhanced CAR T-cells demonstrated superior in vivo antitumor activity.
Conclusions:
- CAR spacer modification is a viable strategy to enhance CAR T-cell therapy.
- Optimizing CAR components can lead to more effective cancer treatments.
- This approach offers a novel way to improve CAR T-cell potency and clinical outcomes.
